Global Medical REIT Inc. (GMRE)

We are in the midst of the biggest retail sales period of the year. Yet, investors are skeptical about bargains in the stock market. Buy a bigger income stream at cheaper prices. We discuss our top defensive picks with up to 8% yields.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ.

Global Medical REIT Inc. has launched its 8.00% Series B Cumulative Redeemable Preferred Stock GMRE.PR.B, targeting high-yield seeking investors. GMRE-B offers a high yield but is considered highly speculative, with no credit rating and a risk profile similar to Single-B rated debt. Recent red flags for GMRE include a reverse stock split, a dividend cut, and a debt-heavy capital structure, warranting extra caution for investors.

Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, three have given a buy

I invest most of my capital in REITs. Even then, I'm bearish on a lot of them. This is a sector in which you need to be very selective to succeed.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on November 20, 2025, subject to customary closing conditions. The Company expects to rece.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the commencement of an underwritten public offering of shares of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”), subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional shares of Series B Preferred Stock to cover over-allotments, if any. The Company intends to use the.

M&A activity is surging in infrastructure and real estate as regulatory and financial barriers ease, unlocking value in discounted public assets. Public REITs and infrastructure stocks trading below NAV are prime targets for private equity buyouts, often at significant premiums to market prices. Top buyout candidates include Global Medical REIT (GMRE) and Farmland Partners (FPI), both trading at deep discounts to their underlying asset values.

Global Medical REIT (GMRE) is upgraded to Strong Buy due to improved fundamentals, sustainable dividend, and management's optimistic outlook, prompting me to build a position recently. GMRE reported solid AFFO growth, expects near 96% occupancy, and executed strategic asset recycling and significant refinancing to strengthen its balance sheet. Recent refinancing greatly extended debt maturities and lowered rates, while macro tailwinds like rate cuts could further boost AFFO and valuation.

Global Medical REIT Inc. ( GMRE ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Jamie Barber - General Counsel & Corporate Secretary Mark Decker - President, CEO & Director Robert Kiernan - CFO & Treasurer Danica Holley - Chief Operating Officer Alfonzo Leon - Chief Investment Officer Conference Call Participants Wesley Golladay - Robert W. Baird & Co. Incorporated, Research Division Robin Haneland - BMO Capital Markets Equity Research Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division Robert Stevenson - Janney Montgomery Scott LLC, Research Division Gaurav Mehta - Alliance Global Partners, Research Division John Massocca - B.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced financial results for the three and nine months ended September 30, 2025 and other data. NOTE: All share and per share data have been adjusted for all periods presented to reflect the Company's one-for-five reverse stock split that was effective September 19, 2025. Third Quarter 2025 and Other Highlights Net loss attributable to common stockholders was $6.0 million, or $0.45 per dilu.

Real Estate Investment Trusts, or REITs, are often a favorite among income investors. They offer regular dividends, provide easy exposure to tangible assets, and can serve as a natural hedge against inflation.

Don't we all love dividend stocks? A little extra income each quarter can go a long way, especially if the stock has a high yield.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its third quarter 2025 financial results after the market closes on Tuesday, November 4, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, November 5, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer.

U.S. equity markets tumbled in a sudden jolt of volatility as investors - already flying blind on key data - reacted to a surprise, massive tariff announcement on Chinese imports. The White House announced a 100% added tariff on all Chinese imports beginning next month - up from 30% currently - as retaliation to new export controls on rare minerals. The CBOE Volatility Index surged to the highest levels since mid-May in a sudden onset of angst following several months of relatively tranquil market conditions.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that it entered into an amended and restated credit facility (the “Amended and Restated Credit Facility”) that extends the maturities of its borrowings and, among other things, includes the following terms: Extends the initial maturity date of the existing $400 million revolver component of the credit facility to October 2029 with two, six-month extension options available at the Comp.